Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer (Q77849015)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

phase II clinical trial

1 reference

1 reference

9

E E Vokes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

S Mani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J W Kugler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J A Knost

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D F Sciortino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Gibbons

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J C Garcia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R H Ansari

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R L Schilsky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

275-278

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10360609%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/a:1006100116229

8 December 2019

exact match

0 references

cites work

Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

1 reference

12 December 2020

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors

1 reference

12 December 2020

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

1 reference

12 December 2020

Gemcitabine: current status of phase I and II trials

1 reference

12 December 2020

Colorectal cancer: hepatic-directed therapy--the role of surgery, regional chemotherapy, and novel modalities.

1 reference

12 December 2020

Phase II study of gemcitabine in advanced colorectal adenocarcinoma

1 reference

12 December 2020

Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group.

1 reference

12 December 2020

Metastatic colorectal cancer: advances in biochemical modulation and new drug development

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020